Memory and Brain Wellness Center at Harborview

Seattle, Washington 98104

0 studies enrolling now · 2 studies all time

What they study most

Alzheimer Disease

Studies at this site

• Simufilam 100 mg for Mild-to-Moderate Alzheimer's Disease — Completed
• Open-label Extension for Phase 3 Clinical Trials of Simufilam — Stopped early